Repligen | RGEN - Market Capitalization


Repligen reported $9.87B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Align Technology USD 10.33B 1.75B Sep/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Bruker USD 9.16B 3.66B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Danaher USD 157.81B 18.96B Sep/2026
Dentsply International USD 2.13B 191M Jun/2026
General Electric Aerospace USD 324.02B 65.91B Sep/2026
Henry Schein USD 9.68B 1.4B Jun/2026
Illumina USD 40.77B 14.06B Sep/2026
IQVIA Holdings USD 44.25B 12B Sep/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
Repligen USD 10.85B 3.15B Sep/2026
Revvity USD 12.69B 2.75B Jun/2026
Standard Biotools USD 359M 133M Mar/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
Waters USD 37.24B 7.38B Jun/2026
West Pharmaceutical Services USD 26.09B 730M Sep/2026